Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

Marie Skłodowska-Curie Action · Finished

COSMOS Curved Optoelectronic System to Monitor Ocular Signals

Coordinator
Fondazione Istituto Italiano Di Tecnologia, Italy
Runs
1 September 2022 to 31 August 2024
Status
Finished
EU funding
€173k
Total cost
—
Partners
2 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101064443

What the project is doing

In the project's own words, from its summary on CORDIS.

COSMOS is a highly multi-disciplinary project that will deliver the first technology for the continuous recording of cell resting membrane potentials. Biological electric fields arise by ion transport across cell membranes and tissues, and represent a crucial cue in guiding cellular differentiation (e.g., stem cells), mutation (e.g., cancer cells), and migration (e.g., wound healing). However, the underlying mechanisms behind these phenomena are yet to be fully discovered.

This is because this data is currently hard to access with existing technologies: microelectrode arrays rely on electroporation (i.e. probing the cell membrane with consequent disruption, which makes it challenging to perform prolonged measurements), the patch-clamp method has a low throughput, and novel optical technologies mainly addressed the measurement of action potentials. However, most cells in the human body do not fire action potentials, and they communicate in a narrower electrical range.

COSMOS will implement a platform to perform contact-free recordings of membrane potentials by optically mirroring the cell membrane charge. This technology will be first applied in testing corneal regenerative technologies (topical drugs, limbal stem cells, post-corneal transplant monitoring), as corneal wounds are an excellent model to study electric field-regulated cell behavior. COSMOS will provide the technological tool to enable addressing a fundamental scientific question, as well as pave the way towards new diagnostic methods, therapeutic strategies, and in vitro drug testing platforms.

Topics

Who is involved

OrganisationCityCountryRole
Fondazione Istituto Italiano Di TecnologiaGenovaItalyCoordinator
Universita Degli Studi Di Modena E Reggio EmiliaModenaItalyAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI